Ajay Piramal’s 20-20 game planThree years after selling its generics business to Abbott, the group is ready with a new strategy on becoming a $20-billion company by 2020

New Drug Approvals

Twenty is an important number for Ajay Piramal, founder of thePiramal Group. Whether it is the target of 20 per cent annual growth or the goal of taking market capitalisation to $20 billion by 2020, the number is key in his scheme of things.

READ ALL AT

http://www.business-standard.com/article/companies/ajay-piramal-s-20-20-game-plan-113081901285_1.html

View original post